间期乳腺癌与筛查检出乳腺癌的发病率和危险因素
该基于人群的队列研究纳入瑞典斯德哥尔摩527144名受邀乳腺X线筛查的无癌女性,随访至2020年。结果显示,29049名女性(5.5%)诊断为乳腺癌,其中筛查检出乳腺癌10631例(2.0%),间期乳腺癌4369例(0.8%)。间期乳腺癌占筛查人群中乳腺癌的比例约30%,且随年龄增长而下降。乳腺癌家族史(HR 1.85)、间期乳腺癌家族史(HR 2.92)及遗传性乳腺癌卵巢癌(HR 1.45)与间期乳腺癌风险升高相关。
要点
- 间期乳腺癌占筛查人群中乳腺癌的比例约30%,且随年龄增长而下降。
- 乳腺癌家族史(HR 1.85)、间期乳腺癌家族史(HR 2.92)与间期乳腺癌风险升高相关。
- 间期乳腺癌女性ER阴性比例高于筛查检出乳腺癌女性(22% vs 11%)。
核心结论
- 该队列研究结果提示,间期乳腺癌发生率未随年龄筛查而下降,实施考虑间期乳腺癌特异性危险因素的风险筛查对改善结局是必要的。
研究设计与样本
- 这项基于人群的队列研究于1989年1月至2020年3月开展,随访至2020年,平均(SD)随访13(8.3)年,统计分析于2023年2月至2024年6月进行。
- 研究纳入居住在瑞典斯德哥尔摩的527144名无癌女性,她们在1989年至2020年间受邀接受乳腺X线筛查(年龄40-74岁)。
- 另纳入参与Karolinska Mammography Project for Risk Prediction of Breast Cancer研究且有乳腺X线数据的女性队列。
主要发现
- 共有29049名女性(5.5%)诊断为乳腺癌,其中筛查检出乳腺癌10631例(2.0%),间期乳腺癌4369例(0.8%)。
- 筛查检出乳腺癌和间期乳腺癌的发病率在研究期间均上升。
- 间期乳腺癌占筛查人群中乳腺癌的比例约30%,且随年龄增长而下降。
- 与间期乳腺癌风险升高相关的因素包括首次分娩年龄较大、教育水平较高、激素替代治疗和乳腺X线密度较高。
- 乳腺癌家族史(HR 1.85;95%CI 1.72-1.99)、间期乳腺癌家族史(HR 2.92;95%CI 2.39-3.55)和遗传性乳腺癌卵巢癌(HR 1.45;95%CI 1.36-1.54)与间期乳腺癌风险升高相关,且风险随年龄低于中位年龄时诊断的亲属数量增加而进一步升高。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Mammographic screening is the only proven method for early detection and mortality reduction of breast cancer (BC). However, many patients are missed at prior screening; thus, they receive their diagnosis between the interval of screening rounds, called interval cancer (IntCa). Some IntCas are fast growing between screening rounds. OBJECTIVE: To investigate the incidence and proportion of IntCa and screen-detected breast cancer (ScrCa) and identify factors associated with IntCa. DESIGN, SETTING, AND PARTICIPANTS: This population-based cohort study was conducted from January 1989 to March 2020, with follow-up until 2020 and a mean (SD) follow-up of 13 (8.3) years. The statistical analysis was performed from February 2023 to June 2024. It included cancer-free women (N = 527 144) residing in Stockholm, Sweden, who were invited to undergo mammography screening (aged 40-74 years) during 1989 to 2020. An additional cohort of women were included who were participating in the Karolinska Mammography Project for Risk Prediction of Breast Cancer study and had mammography data available. EXPOSURES: Family cancer history (defined from the Swedish Multi-Generation Register and Cancer Register), mammographic density, and various demographic, reproductive, and other factors (multiple Swedish registers). MAIN OUTCOMES AND MEASURES: Incidence of ScrCa and IntCa (defined from the Swedish Cancer Register in conjunction with individual screening histories). RESULTS: A total of 29 049 women (5.5%) received a diagnosis of BC, of whom 10 631 (2.0%) had ScrCa and 4369 (0.8%) IntCa. ScrCa and IntCa incidences increased during the period. The proportion of IntCa among screened patients with BC was around 30%, which decreased with older age. Factors associated with increased risk of IntCa included older age at first childbirth, higher education level, hormone replacement therapy, and higher mammographic density. Risk estimates of family cancer history on IntCa were family history of BC (hazard ratio [HR], 1.85; 95% CI, 1.72-1.99), family history of IntCa (HR, 2.92; 95% CI, 2.39-3.55), and hereditary breast and ovarian cancers (HR, 1.45; 95% CI, 1.36-1.54), with risk further elevated with the number of relatives who received a diagnosis when younger than the median age. Women with IntCa were more likely to have estrogen receptor (ER)-negative cancers than women with ScrCa (22% vs 11%), and having family history of ER-negative BC was associated with 3-fold risk for ER-negative IntCa. CONCLUSIONS AND RELEVANCE: The results of this cohort study suggest that IntCa rates have not decreased with age-based screening, and implementing risk-based screening considering IntCa-specific risk factors is necessary for improving outcomes.
引用
- Zhang Y, Rodriguez J, Mao X, et al. Incidence and Risk Factors of Interval and Screen-Detected Breast Cancer. JAMA Oncol. 2025. PMID: 40146116. doi:10.1001/jamaoncol.2025.0167
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。